• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有无细胞外ATP的情况下,涡旋速度对新鲜与储存血小板聚集的影响。

Influence of vortex speed on fresh versus stored platelet aggregation in the absence and presence of extracellular ATP.

作者信息

Soslau G, Schechner A J, Alcasid P J, Class R

机构信息

Department of Biochemistry, MCP Hahnemann School of Medicine, Philadelphia, Pennsylvania 19102-1192, USA.

出版信息

Thromb Res. 2000 Jan 15;97(2):15-27. doi: 10.1016/s0049-3848(99)00124-3.

DOI:10.1016/s0049-3848(99)00124-3
PMID:10688331
Abstract

Platelets are subjected to vastly differing shear forces under laminar and nonlaminar flow patterns throughout the tortuous cardiovascular system. Different activation pathways appear to be associated with platelet adhesion and aggregation under high shear rates vs. low shear rates. We found that platelets continue to aggregate at very low stirring rates (100 RPM) and low shear forces although significantly less than at high stirring rates (1000 RPM). These conditions may model vortices encountered in vivo, such as downstream of partially occluded blood vessels. The extent of agonist-induced platelet aggregation, at varying stir rates, remained essentially unchanged between 1200 and 600 RPM. This was true for both freshly prepared and stored platelets even though the extent of aggregation was significantly reduced with stored platelets. Agonists used were thrombin, thrombin receptor activating peptide (TRAP), SFLLRNP, the thromboxane A2 mimetic, U46619, plus epinephrine and ADP+epinephrine. At lower stir rates (100-400 RPM), little or no difference in aggregation levels was observed between fresh and stored platelets, depending upon agonist used. This may indicate that old and young platelets, in vivo, would be equally active at vessel walls exposed to blood flowing through a slow vortex at low shear rates. ATP, released from activated platelets, may act as a potent regulator of platelet aggregation within a vortex where the resident time of platelets and bioactive molecules is greater than in laminar flow regions. High levels of extracellular ATP (100 microM) inhibited agonist-induced aggregation of fresh platelets to a greater extent than stored platelets, except with ADP+epinephrine where the converse was observed. Inhibition, in general, appeared to be inversely related to stir rates. Low levels of extracellular ATP (10 nM, 1 microM) generally stimulated agonist-induced aggregations independent of stir rates and to a greater extent with stored platelets than fresh platelets. Unraveling how hemostasis functions within microenvironments may facilitate ways to further regulate this process.

摘要

在整个曲折的心血管系统中,血小板在层流和非层流模式下会受到截然不同的剪切力。在高剪切速率与低剪切速率下,不同的激活途径似乎与血小板的黏附和聚集有关。我们发现,血小板在非常低的搅拌速率(100转/分钟)和低剪切力下仍会继续聚集,尽管明显少于在高搅拌速率(1000转/分钟)下的聚集。这些条件可能模拟了体内遇到的涡流,例如部分阻塞血管的下游。在1200至600转/分钟之间,不同搅拌速率下激动剂诱导的血小板聚集程度基本保持不变。对于新鲜制备的血小板和储存的血小板都是如此,尽管储存血小板的聚集程度明显降低。使用的激动剂有凝血酶、凝血酶受体激活肽(TRAP)、SFLLRNP、血栓素A2模拟物U46619,以及肾上腺素和ADP + 肾上腺素。在较低的搅拌速率(100 - 400转/分钟)下,新鲜血小板和储存血小板之间的聚集水平几乎没有差异,这取决于所使用的激动剂。这可能表明,在体内,老年和年轻血小板在暴露于低剪切速率下缓慢涡流中的血管壁处具有同等活性。从活化血小板释放的ATP可能作为血小板在涡流中聚集的有效调节剂,在涡流中血小板和生物活性分子的停留时间比在层流区域更长。高浓度的细胞外ATP(100微摩尔)比储存血小板更能抑制新鲜血小板的激动剂诱导聚集,但ADP + 肾上腺素的情况则相反。一般来说,抑制作用似乎与搅拌速率呈负相关。低浓度的细胞外ATP(10纳摩尔、1微摩尔)通常会刺激激动剂诱导的聚集,且与搅拌速率无关,并且储存血小板比新鲜血小板的刺激程度更大。弄清楚止血在微环境中的作用机制可能有助于找到进一步调节这一过程的方法。

相似文献

1
Influence of vortex speed on fresh versus stored platelet aggregation in the absence and presence of extracellular ATP.在有无细胞外ATP的情况下,涡旋速度对新鲜与储存血小板聚集的影响。
Thromb Res. 2000 Jan 15;97(2):15-27. doi: 10.1016/s0049-3848(99)00124-3.
2
Permanent lesions of stored platelets correlate to pH and cell count while reversible lesions do not.储存血小板的永久性损伤与pH值和细胞计数相关,而可逆性损伤则不然。
Proc Soc Exp Biol Med. 1998 Feb;217(2):219-27. doi: 10.3181/00379727-217-44226.
3
Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.细胞外ATP抑制激动剂诱导的人血小板内钙的动员。
Biochim Biophys Acta. 1995 Jul 20;1268(1):73-80. doi: 10.1016/0167-4889(95)00051-s.
4
A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation.细胞外ATP在调节血小板聚集过程中可能具有的双重生理作用。
Biochim Biophys Acta. 1997 Feb 4;1355(2):131-40. doi: 10.1016/s0167-4889(96)00123-1.
5
Aggregation of human and canine platelets: modulation by purine nucleotides.人和犬血小板的聚集:嘌呤核苷酸的调节作用
Thromb Res. 1993 Oct 15;72(2):127-37. doi: 10.1016/0049-3848(93)90214-9.
6
Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.组织蛋白酶G预处理血小板对其随后对聚集剂反应的影响。
Thromb Res. 1999 Sep 15;95(6):315-23. doi: 10.1016/s0049-3848(99)00051-1.
7
Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.去除血小板外的钠离子可消除肾上腺素、二磷酸腺苷(ADP)和凝血酶刺激的人血小板中对吲哚美辛敏感的分泌。
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5320-4. doi: 10.1073/pnas.80.17.5320.
8
ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.二磷酸腺苷(ADP)分泌及随后的P2Y12受体信号传导在凝血酶诱导的人血小板细胞外调节蛋白激酶2(ERK2)激活中起关键作用。
Thromb Haemost. 2004 Jul;92(1):114-23. doi: 10.1160/TH03-12-0729.
9
Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation.凝血酶受体激活肽(SFLLRN)增强剪切力诱导的血小板微囊泡形成。
J Lab Clin Med. 2000 Jan;135(1):66-72. doi: 10.1016/s0022-2143(00)70022-9.
10
Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.分泌型ADP在凝血酶诱导的人血小板磷脂酶D激活过程中起核心作用。
Thromb Haemost. 1998 Dec;80(6):976-81.

引用本文的文献

1
Hemodynamic Performance of Dysfunctional Prosthetic Heart Valve with the Concomitant Presence of Subaortic Stenosis: In Silico Study.伴有主动脉瓣下狭窄的功能失调人工心脏瓣膜的血流动力学性能:计算机模拟研究
Bioengineering (Basel). 2020 Aug 7;7(3):90. doi: 10.3390/bioengineering7030090.